Vikram Karnani is President and CEO of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 96,989 shares of COLL, which is worth approximately $4.46 Million. The most recent transaction as insider was on Nov 12, 2025, when has been sold 8,983 shares (Common Stock) at a price of $47.35 per share, resulting in proceeds of $425,345. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97K
8.48% 3M change
8.48% 12M change
Total Value Held $4.46 Million

Vikram Karnani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 12 2025
SELL
Payment of exercise price or tax liability
$425,345 $47.35 p/Share
8,983 Reduced 8.48%
96,989 Common Stock
Nov 12 2024
BUY
Grant, award, or other acquisition
-
105,972 Added 50.0%
105,972 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
DYN
Dyne Therapeutics, Inc. Healthcare
VK

Vikram Karnani

President and CEO
Dublin, L2

Track Institutional and Insider Activities on COLL

Follow COLLEGIUM PHARMACEUTICAL, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL